Cancer Family
Musculoskeletal Neoplasm
CI-CAN-00000278Explore in graph →
Non-malignant212 active trials5 approved drugs54 evidence items
- NCIt
- C166354
Loading cancer entity…
Cancer Family
CI-CAN-00000278Explore in graph →
Clinical trials
1,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03972917 | Observation of Long-term Effects on Endometrium and Uterine Fibroids in Women With Ulipristal Acetate Therapy | completed | — | 89 | University of Campania Luigi VanvitelliOTHER | 1 | Jan 18, 2023 | clinicaltrials |
| NCT05643339 | The Reproducibility of Microvascular Flow Imaging in Fibroids and Its Correlation With 2D and 3D Power Doppler Outcomes(MVF) | completed | — | 30 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
| 1 |
| Dec 8, 2022 |
| clinicaltrials |
| NCT05631002 | Chemical Shift Encoding-based Water-fat Magnetic Resonance Imaging in Spinal Tumors | unknown | — | 150 | Peking University Third HospitalOTHER | 1 | Nov 30, 2022 | clinicaltrials |
| NCT05628792 | In Vivo Depiction Of Bone Vascularization With UHR-CT CT And Deep Learning Algorithm Reconstruction: A Preliminary Study | unknown | — | 20 | Central Hospital, Nancy, FranceOTHER | 0 | Nov 29, 2022 | clinicaltrials |
| NCT04374448 | Utility of Indocyanine Green Fluorescence in Endoscopic Sinonasal and Skull Base Surgery(NIRFICG) | unknown | N/A | 40 | St. Paul's Sinus CentreOTHER | 0 | Nov 14, 2022 | clinicaltrials |
| NCT00396279 | Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone | completed | Phase 2 | 37 | AmgenINDUSTRY | 0 | Nov 8, 2022 | clinicaltrials |
| NCT03389724 | Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia | completed | Phase 3 | 245 | Children's Cancer Hospital Egypt 57357OTHER | 1 | Nov 8, 2022 | clinicaltrials |
| NCT04255576 | Efficacy and Safety of JMT103 in Patients With Giant Cell Tumor of Bone | unknown | Phase 1 / Phase 2 | 139 | Shanghai JMT-Bio Inc.INDUSTRY | 1 | Oct 14, 2022 | clinicaltrials |
| NCT02620748 | Use of Intravenous Tranexamic Acid During Myomectomy(TA) | completed | Phase 1 | 60 | George Washington UniversityOTHER | 1 | Oct 13, 2022 | clinicaltrials |
| NCT00680992 | Study of Denosumab in Subjects With Giant Cell Tumor of Bone | completed | Phase 2 | 535 | AmgenINDUSTRY | 12 | Sep 22, 2022 | clinicaltrials |
| NCT03959033 | Patient Reported Outcome Measures (PROMs) With Trabectedin | terminated | — | 7 | University of LeedsOTHER | 1 | Aug 31, 2022 | clinicaltrials |
| NCT05515068 | Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas(COSS-Registry) | not yet recruiting | — | 1,000 | Klinikum StuttgartOTHER | 0 | Aug 25, 2022 | clinicaltrials |
| NCT02601209 | Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma | terminated | Phase 1 / Phase 2 | 151 | National Cancer Institute (NCI)NIH | 1 | Aug 23, 2022 | clinicaltrials |
| NCT05500118 | Establishment of a Decision Aid Tool for Asymptomatic Small Leiomyoma and Analysis of Influencing Factors for Clinical Decision-making Using HIFU | recruiting | — | 120 | Shenzhen Maternity & Child Healthcare HospitalOTHER | 1 | Aug 12, 2022 | clinicaltrials |
| NCT03442985 | An Efficacy and Safety Study of Palovarotene for the Treatment of MO(MO-Ped) | terminated | Phase 2 | 193 | Clementia Pharmaceuticals Inc.INDUSTRY | 12 | Aug 1, 2022 | clinicaltrials |
| NCT05475938 | Application of Painting Analysis and Psychotherapy in Children With Bone Tumors | completed | N/A | 40 | Henan Cancer HospitalOTHER_GOV | 1 | Jul 29, 2022 | clinicaltrials |
| NCT05405179 | Simultaneous Dental Implant in Free Vascularized Bone Flaps for Jaw Reconstruction | unknown | N/A | 25 | The University of Hong KongOTHER | 1 | Jul 19, 2022 | clinicaltrials |
| NCT04563806 | Safety of MRI Compatible Hardware for MRI-based Image Guidance During Spine Surgery | terminated | Early Phase 1 | 16 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 11, 2022 | clinicaltrials |
| NCT03400956 | Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4) | terminated | Phase 3 | 103 | BayerINDUSTRY | 5 | Jun 30, 2022 | clinicaltrials |
| NCT03245450 | Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors | completed | Phase 1 / Phase 2 | 40 | Eisai Inc.INDUSTRY | 8 | Jun 28, 2022 | clinicaltrials |
| NCT05427825 | ERAS Anesthetic Care for Metastatic Spine Cancer Resection | unknown | N/A | 120 | National Taiwan University HospitalOTHER | 1 | Jun 28, 2022 | clinicaltrials |
| NCT05419414 | The Use of Shear Wave Elastography, Transvaginal Ultrasound and Pelvic MRI in the Diagnosis of Adenomyosis | completed | N/A | 65 | Istanbul UniversityOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT03905174 | Massive Implants the Next Generation(MING) | unknown | N/A | 30 | Iva HauptmannovaOTHER | 1 | Jun 7, 2022 | clinicaltrials |
| NCT05402865 | A Real-world Study on Patients of Unresectable Giant Cell Tumor of Bone | completed | — | 301 | Shanghai JMT-Bio Inc.INDUSTRY | 1 | Jun 2, 2022 | clinicaltrials |
| NCT05397522 | The Effects of Observer Presence and Type on Patients' Perception of Exercise After Bone Tumor Resection-A Qualitative Study | unknown | N/A | 30 | Istanbul Medeniyet UniversityOTHER | 1 | May 31, 2022 | clinicaltrials |
| NCT00474331 | Gene Mutations and Orthopaedic Symptoms Correlation of Multiple Hereditary Exostoses: Multicentre Project | suspended | — | 2,000 | University of British ColumbiaOTHER | 1 | May 18, 2022 | clinicaltrials |
| NCT00474448 | The Health-Related Quality of Life in Patients With Hereditary Multiple Exostoses | completed | — | 200 | University of British ColumbiaOTHER | 1 | May 18, 2022 | clinicaltrials |
| NCT02377492 | Paracervical Vasopressin Injection Compared With Intramyometrial Vasopressin in Abdominal Myomectomy | withdrawn | N/A | 0 | University Hospitals Cleveland Medical CenterOTHER | 1 | May 12, 2022 | clinicaltrials |
| NCT04856306 | Myomectomy vs Uterine Artery Embolization vs GnRh Antagonist for AUB-L(Magical) | unknown | — | 300 | Medstar Health Research InstituteOTHER | 1 | May 5, 2022 | clinicaltrials |
| NCT03074318 | Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery | terminated | Phase 1 / Phase 2 | 35 | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 29, 2022 | clinicaltrials |
| NCT00346164 | Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma | completed | Phase 3 | 588 | Children's Oncology GroupNETWORK | 5 | Apr 28, 2022 | clinicaltrials |
| NCT02821507 | Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma | completed | Phase 2 | 70 | Leiden University Medical CenterOTHER | 2 | Apr 20, 2022 | clinicaltrials |
| NCT03103087 | LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids | completed | Phase 3 | 382 | Myovant Sciences GmbHINDUSTRY | 8 | Apr 20, 2022 | clinicaltrials |
| NCT03049735 | LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids | completed | Phase 3 | 388 | Myovant Sciences GmbHINDUSTRY | 6 | Apr 19, 2022 | clinicaltrials |
| NCT03041701 | Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma | terminated | Phase 1 / Phase 2 | 14 | National Cancer Institute (NCI)NIH | 1 | Apr 14, 2022 | clinicaltrials |
| NCT02239861 | TAA-Specific CTLS for Solid Tumors (TACTASOM) | completed | Phase 1 | 16 | Baylor College of MedicineOTHER | 1 | Apr 12, 2022 | clinicaltrials |
| NCT02013336 | Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors | unknown | Phase 1 | 30 | South Plains Oncology ConsortiumNETWORK | 1 | Mar 31, 2022 | clinicaltrials |
| NCT02050919 | Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma | completed | Phase 2 | 20 | OHSU Knight Cancer InstituteOTHER | 1 | Mar 21, 2022 | clinicaltrials |
| NCT02349971 | Safety and Feasibility of MR-Guided High Intensity Focused Ultrasound (MR-HIFU) Ablation of Osteoid Osteoma in Children | completed | N/A | 9 | Children's National Research InstituteOTHER | 1 | Mar 11, 2022 | clinicaltrials |
| NCT05266534 | The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets(myomectomy) | recruiting | N/A | 162 | Wael Elbanna ClinicOTHER | 1 | Mar 4, 2022 | clinicaltrials |
| NCT02739555 | Zoledronic Acid Compared to Percutaneous Treatment in Osteoid Osteoma(BISPHOO) | terminated | Phase 3 | 15 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 23, 2022 | clinicaltrials |
| NCT00095017 | Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083) | withdrawn | Phase 2 | 0 | Organon and CoINDUSTRY | 0 | Feb 16, 2022 | clinicaltrials |
| NCT02982941 | Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors | completed | Phase 1 | 25 | MacroGenicsINDUSTRY | 1 | Feb 8, 2022 | clinicaltrials |
| NCT02737553 | Laparoscopic Enclosed Morcellation; Electromechanic Morcellation vs Vaginal Removal | completed | N/A | 118 | Ege UniversityOTHER | 1 | Jan 24, 2022 | clinicaltrials |
| NCT05204524 | Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma | unknown | N/A | 28 | Chinese Academy of Medical SciencesOTHER | 1 | Jan 24, 2022 | clinicaltrials |
| NCT02452554 | Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma | completed | Phase 2 | 62 | Children's Oncology GroupNETWORK | 1 | Jan 13, 2022 | clinicaltrials |
| NCT05182853 | Voiding Disorders in Children After Sacrococcygeal Teratoma Resection(TSC-URO) | completed | — | 8 | University Hospital, MontpellierOTHER | 1 | Jan 11, 2022 | clinicaltrials |
| NCT04911972 | Functional Muscle Transfers in Lower Limb Sarcoma: 3D Gait Analysis and Environmental Simulation | completed | — | 27 | NHS Greater Glasgow and ClydeOTHER | 1 | Dec 13, 2021 | clinicaltrials |
| NCT05151393 | Correlation Between Serum Vitamin D3 and Incidence of Uterine Leiomyoma | unknown | — | 80 | Ain Shams UniversityOTHER | 0 | Dec 9, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Jan 18, 2023source: clinicaltrials